Latest News

Non-invasive first trimester blood test reliably detects Down's syndrome and other genetic fetal abnormalities

New research has found that routine screening using a non-invasive test that analyzes fetal DNA in a pregnant woman's blood can accurately detect Down's syndrome and other genetic fetal abnormalities in the first trimester. The results suggest that the test is superior to currently available screening strategies and could reshape standards in prenatal testing.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Memory decline among menopausal women could be next research frontier for hypnotic relaxation therapy

  • Immersed in violence: How 3-D gaming affects video game players

  • Three-minute assessment successfully identifies delirium in hospitalized elders

  • Largest study of Hispanics/Latinos finds depression, anxiety rates vary widely among groups

  • Stress-related inflammation may increase risk for depression

  • No relationship between moderate adolescent cannabis use, exam results or IQ, large study shows

  • Biochemical cause of seasonal depression (SAD) confirmed by researchers

  • For prescription drug addiction treatment, buprenorphine maintenance trumps detoxification

  • Key factor in transition from moderate to problem drinking

  • A rich vocabulary can protect against cognitive impairment

  •